Kiran Musunuru Profile Banner
Kiran Musunuru Profile
Kiran Musunuru

@kiranmusunuru

Followers
3,404
Following
92
Media
220
Statuses
1,191

Cardiologist, geneticist, and gene editor. Author of #TheCRISPRGeneration and #GenomeEditingAPracticalGuide

Philadelphia, USA
Joined March 2009
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@kiranmusunuru
Kiran Musunuru
1 year
When I started working on #CRISPR to fight heart disease >10 years ago, I never imagined it might lead to cures for rare inborn errors of metabolism. Here’s how it’s happening! Presented/published today #ASHG23 #ASHG2023 @GeneticsSociety plenary + @AJHGNews + @HGGAdvances 🧵
Tweet media one
@kiranmusunuru
Kiran Musunuru
4 years
How to use #CRISPR gene editing to fight heart disease, the #1 killer worldwide: A thread 10+ years in the making. This one starts in 2009 when I was a postdoc in @skathire lab @MassGeneralNews / @broadinstitute studying ❤ risk factors like cholesterol & triglycerides. (thread)
Tweet media one
21
269
883
2
92
361
@kiranmusunuru
Kiran Musunuru
3 years
A milestone in modern medicine: 1st therapeutic in vivo gene editing in human patients! From Julian Gillmore, @intelliatweets & colleagues out today @NEJM : Here’s an overview of a new potential treatment for transthyretin (ATTR) amyloidosis. (thread)
Tweet media one
18
462
1K
@kiranmusunuru
Kiran Musunuru
4 years
How to use #CRISPR gene editing to fight heart disease, the #1 killer worldwide: A thread 10+ years in the making. This one starts in 2009 when I was a postdoc in @skathire lab @MassGeneralNews / @broadinstitute studying ❤ risk factors like cholesterol & triglycerides. (thread)
Tweet media one
21
269
883
@kiranmusunuru
Kiran Musunuru
3 years
The latest chapter in a long-running story, in @Nature & @NatureBiotech : To recap, here’s a brief history of in vivo genome editing—focused on 1 gene with lots of 🥇 proofs of concept: #PCSK9 (apologies to other genes!) (thread)
Tweet media one
6
135
485
@kiranmusunuru
Kiran Musunuru
11 months
The culmination of 10+ years of work to use #CRISPR gene editing to fight heart disease! @ambellinger @VerveTx $VERV presenting the interim data from the ongoing heart-1 Phase 1b clinical trial of VERVE-101 base editing for HeFH patients, at #AHA23 now. Let’s start! 🧵
Tweet media one
@kiranmusunuru
Kiran Musunuru
4 years
How to use #CRISPR gene editing to fight heart disease, the #1 killer worldwide: A thread 10+ years in the making. This one starts in 2009 when I was a postdoc in @skathire lab @MassGeneralNews / @broadinstitute studying ❤ risk factors like cholesterol & triglycerides. (thread)
Tweet media one
21
269
883
7
63
327
@kiranmusunuru
Kiran Musunuru
10 months
A #CRISPR milestone - the first U.S. FDA approval of a gene-editing therapy! Here’s a quick recap of the story of how it came to be: “How CRISPR + GWAS Cured Sickle Cell Disease” 🧵
2
66
217
@kiranmusunuru
Kiran Musunuru
5 years
Lulu and Nana, humanity’s first gene-edited babies, both have some CRISPR edits in the CCR5 gene, as He Jiankui (JK) attempted. His goal was to confer HIV resistance. Unfortunately, the editing turned out quite badly, as shown by *his own data* in *his own manuscript*. (thread)
Tweet media one
@kiranmusunuru
Kiran Musunuru
5 years
Today is the 1-year anniversary of @antonioregalado breaking the news about Chinese scientist He Jiankui (JK) using gene-edited human embryos to establish pregnancies. It’s time to break the silence. (thread)
9
106
171
3
136
186
@kiranmusunuru
Kiran Musunuru
5 years
Today is the 1-year anniversary of @antonioregalado breaking the news about Chinese scientist He Jiankui (JK) using gene-edited human embryos to establish pregnancies. It’s time to break the silence. (thread)
9
106
171
@kiranmusunuru
Kiran Musunuru
3 years
In 2014, I predicted that it would take at least 10 years for #CRISPR gene editing for ❤️ disease to be ready for testing in people: Fast forward just 7 years, to 2021: excited that the goal is within reach! via @WSJ
4
19
99
@kiranmusunuru
Kiran Musunuru
4 years
19/ Today @VerveTx announced new data from non-human primates in which LNP-delivered adenine base editor ⬇️ PCSK9 or ANGPTL3 in the liver. PCSK9: 67% editing 89%⬇️PCSK9 in blood 59%⬇LDL ANGPTL3: 60% editing 95%⬇ANGPTL3 in blood 64%⬇TG 19%⬇LDL
2
34
92
@kiranmusunuru
Kiran Musunuru
4 years
It’s a good day for a scientist when— the protein you worked on for your postdoc is the target of a brand-new FDA-approved drug: *and* the protein you worked on for your PhD thesis is featured in the New York Times:
6
9
89
@kiranmusunuru
Kiran Musunuru
3 years
Beautiful metaphor from @UrnovFyodor : “Imagine you have a car with a flat tire. Gene therapy is taking a fifth wheel and putting it somewhere on the car and hoping it runs. Gene editing is repairing the flat.” How Designer DNA Is Changing Medicine @sciam
2
18
87
@kiranmusunuru
Kiran Musunuru
3 years
If this proves out, a bona fide win for stem cell research!
0
16
77
@kiranmusunuru
Kiran Musunuru
3 years
A win for gene editing and transplantation, via @nytimes
0
22
78
@kiranmusunuru
Kiran Musunuru
4 years
21/ This is an important step—in a long series of steps—to translate genetic discoveries into therapies to fight the preeminent health threat of the 21st century. It’s been an enthralling 10 years—let’s see what the next 10 years bring! from @ginakolata
11
10
76
@kiranmusunuru
Kiran Musunuru
3 years
The pleasure and privilege of working with @skathire for the past 13 years has been all mine! Much more to come 🚀
@skathire
Sek Kathiresan MD
3 years
And this guy - @kiranmusunuru - what a spectacular partnership since that first email from him in 2008 asking if he can join my newly minted research lab as a postdoc to learn common disease genetics Amazing journey.
Tweet media one
1
0
56
1
2
71
@kiranmusunuru
Kiran Musunuru
3 years
11/ In sum, this is a remarkable demonstration of efficacy and safety of a totally new therapeutic modality in a first-in-human study. Many congratulations to the team responsible for this groundbreaking accomplishment!
6
13
60
@kiranmusunuru
Kiran Musunuru
4 years
Showing off my pipetting skills on camera...or, more accurately, *onto* the camera...
5
4
59
@kiranmusunuru
Kiran Musunuru
4 years
Charlie was the chair of my thesis committee when I was a graduate student at @RockefellerUniv , and one of the nicest guys I’ve ever met—so thrilled to see him win the #NobelPrize ! Congratulations to all of the laureates!
@NobelPrize
The Nobel Prize
4 years
BREAKING NEWS: The 2020 #NobelPrize in Physiology or Medicine has been awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus.”
Tweet media one
435
16K
32K
2
9
58
@kiranmusunuru
Kiran Musunuru
4 years
Today the American Heart Association @AHAScience released a Scientific Statement on genetic testing for inherited cardiovascular diseases, published in @Circ_Gen Accompanying commentary by @CarolynHoMD #cardiogen (short thread)
@AHAScience
AHA Science
4 years
AHA Statement on Genetic Testing for Inherited Cardiovascular Diseases
Tweet media one
1
20
34
2
27
47
@kiranmusunuru
Kiran Musunuru
5 years
This Friday, November 29, 2019, is the launch of my book— The CRISPR Generation: The Story of the World’s First Gene-Edited Babies eBook at (available now) Print version at , Amazon, and other sites #TheCRISPRGeneration
Tweet media one
2
28
48
@kiranmusunuru
Kiran Musunuru
5 years
A step forward for somatic gene-editing therapy to treat cardiac and skeletal muscle disease #CRISPR
1
24
44
@kiranmusunuru
Kiran Musunuru
3 years
A wonderful profile of @skathire , my long-time mentor, from @BentheFidler Heart attacks struck Sek Kathiresan's family. He's devoted his life to stopping them. via @BioPharmaDive
1
5
40
@kiranmusunuru
Kiran Musunuru
4 years
Just finished this wonderful read from @KevinADavies . The definitive history of gene editing right up to the present (just missing the #NobelPrize announced the day after it came out). I particularly liked the anecdotes of many key #CRISPR contributors. I heartily recommend it!
@KevinADavies
Kevin Davies
4 years
*** PUBLICATION DAY *** (Hallelujah!) A mere 10 years after 'The $1,000 Genome', I'm delighted to publish EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing @Pegasus_Books . I've poured everything into this book. I hope you like it!
Tweet media one
14
44
146
2
10
34
@kiranmusunuru
Kiran Musunuru
5 years
Today is Thanksgiving in the U.S.—in the spirit of the holiday, I want to focus on a positive story about CRISPR, instead of the misadventures of He Jiankui: “How CRISPR + GWAS (May Have) Cured Sickle Cell Disease” Surely a story about which to be thankful. (thread)
@kiranmusunuru
Kiran Musunuru
5 years
In his manuscript, He Jiankui (JK) barely mentions mosaicism—he didn’t realize (or didn’t care?) that the twins’ embryos were flagrantly mosaic. But he does say “No off-targets, large deletions or pathogenic cancer gene mutations was observed.” His data say otherwise. (thread)
Tweet media one
1
11
19
1
21
36
@kiranmusunuru
Kiran Musunuru
5 years
16/ If you want tips on reading chromatograms like these, sign up to access a recording of a CRISPR workshop by yours truly at the @GeneticsSociety 2019 Annual Meeting—membership not required:
Tweet media one
1
5
34
@kiranmusunuru
Kiran Musunuru
5 years
17/ Tomorrow, I’ll tackle the other major safety concern with germline editing—off-target mutations. Spoiler alert: there were off-target mutations in JK’s embryos. For more details/explanation for today’s thread, refer to #TheCRISPRGeneration at
Tweet media one
3
6
31
@kiranmusunuru
Kiran Musunuru
4 years
Nine months in, with no more sickle cell crises. Amazing.
0
4
34
@kiranmusunuru
Kiran Musunuru
3 years
Still reading? You must be interested in genome editing! If you’re new to editing and want to learn how to do all the types of editing described in this thread, may I recommend my new book: #GenomeEditingAPracticalGuide Available here (and elsewhere):
Tweet media one
1
6
34
@kiranmusunuru
Kiran Musunuru
4 years
#NobelPrize for CRISPR! Congratulations to Jennifer and Emmanuelle!
@NobelPrize
The Nobel Prize
4 years
BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
Tweet media one
727
24K
48K
0
4
34
@kiranmusunuru
Kiran Musunuru
4 years
20/ If these results can be reproduced in human patients, they’d rival or surpass the effects of all existing drugs that lower LDL or TG... ...but with a single treatment, rather than pills every day or injections every few weeks/months. from @sxbegle
2
8
34
@kiranmusunuru
Kiran Musunuru
5 years
8/ Conclusion: Lulu’s embryo was mosaic—a patchwork of cells with different edits, possibly some with no edits. Is the same true of Lulu’s body? I’ll explain tomorrow why mosaicism in the context of human germline editing could have serious, adverse health consequences.
Tweet media one
1
8
32
@kiranmusunuru
Kiran Musunuru
1 year
@GeneticsSociety @AJHGNews @HGGAdvances @VerveTx @ChildrensPhila @KomorLab @NicoleGaudelli @davidrliu @liugroup @Domi_niqueB @mn_whittaker @Xiao_Wang_Penn @AhrensNicklas @PennMedicine @BKleinstiver 21/ Using a dual AAV vector prime editing system developed by @JessieRoseDavis @samagyabanskota @liugroup , we delivered the best PEmax/pegRNA/ngRNA combination into R408W PKU mice: - Phe normalization in 3 weeks (longer than LNPs) - up to 52% whole-liver corrective editing
Tweet media one
1
10
28
@kiranmusunuru
Kiran Musunuru
5 years
UPDATE: new info re: He Jiankui’s (JK’s) targeting of CCR5 in human embryos: Previously I showed a chromatogram from Lulu’s embryo with 3 alleles (instead of the expected 2)—wild-type, -15bp, and ? H/t @biohackinfo and another anonymous source for ID of the 3rd allele. (thread)
@kiranmusunuru
Kiran Musunuru
5 years
9/ Wondering if the chromatogram even shows the claimed -15bp allele? With a little patience, you can pick it out of the peaks. What’s the 3rd allele, then? I can’t figure it out—as best I can tell, it’s a large insertion of random DNA. If you figure it out, I’d love to know.
Tweet media one
2
4
14
3
19
31
@kiranmusunuru
Kiran Musunuru
3 years
2/ Transthyretin (TTR) is expressed in liver, is secreted into blood, and functions as vitamin/hormone transporter. ATTR amyloidosis is caused by abnormal aggregates of destabilized TTR monomers (normally forms tetramers)—either mutant or wild-type—damaging nerves and/or heart.
Tweet media one
1
6
27
@kiranmusunuru
Kiran Musunuru
5 years
6/ There are many positions with 3 peaks. This means there are 3 different alleles in play. Normal cells have a maximum of 2 alleles at 1 genomic position (chromosome pair). The best (only?) explanation: different cells in Lulu’s embryo had different CRISPR edits of CCR5.
Tweet media one
2
4
26
@kiranmusunuru
Kiran Musunuru
5 years
The bedeviling problem of pathogenic variants being reclassified as variants of uncertain significance—after it’s too late. (1/2) via @WSJ
3
19
26
@kiranmusunuru
Kiran Musunuru
4 years
9/ We wondered: was CRISPR just another gene-editing tool? Would it work as well as ZFNs & TALENs? Qiurong Ding in my lab compared CRISPR-Cas9 & TALENs head-to-head across many loci in stem cells. We were stunned: CRISPR-Cas9 blew TALENs out of the water. It wasn’t even close.
Tweet media one
1
10
28
@kiranmusunuru
Kiran Musunuru
3 years
6/ In today’s study, LNPs were used to deliver Cas9 mRNA and #CRISPR guide RNA into hepatocytes in vivo to disrupt TTR gene via non-homologous end-joining (NHEJ). In hepatocytes, Cas9 efficiently edited TTR & induced same 1-bp insertion 99% of the time—very consistent outcome.
Tweet media one
3
6
24
@kiranmusunuru
Kiran Musunuru
3 years
14/ Out today: a study from @schwanklab & colleagues with adenine base editor (ABE) from @NicoleGaudelli @davidrliu @liugroup , delivered by LNPs into NHPs, to knock down liver PCSK9 by splice site editing, resulting in 32% ⬇️ blood PCSK9 protein + 14% ⬇️ LDL-C levels
Tweet media one
1
6
27
@kiranmusunuru
Kiran Musunuru
3 years
CRISPR injected into the blood treats a genetic disease for first time
0
12
25
@kiranmusunuru
Kiran Musunuru
4 years
5/ With exome sequencing so new, 2 students in the lab— @jpirruccello & @DoGenetics —set up a pipeline from scratch. On a wintry Saturday afternoon, the pipeline finally spit out the thrilling answer: Each sibling had 2 nonsense mutations in ANGPTL3—natural gene “knockouts”!
Tweet media one
1
4
25
@kiranmusunuru
Kiran Musunuru
3 years
3/ Patisiran, developed by @Alnylam , is a lipid nanoparticle (LNP)-delivered siRNA that knocks down TTR mRNA in liver. In clinical trial, 0.3-mg/kg dose IV every 3 weeks = 81% ⬇️ blood TTR, halting neurologic disease progression with ⬆️ quality of life:
Tweet media one
1
5
22
@kiranmusunuru
Kiran Musunuru
4 years
15/ The next big innovation in gene editing was the development of cytosine and adenine base editors by the lab of @davidrliu , reported in 2016 & 2017. These base editors allow for specific C➡️T and A➡️G changes in the genome—more precise, more efficient, and safer than Cas9.
Tweet media one
1
6
25
@kiranmusunuru
Kiran Musunuru
1 year
@NobelPrize
The Nobel Prize
1 year
BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Tweet media one
4K
28K
79K
0
1
22
@kiranmusunuru
Kiran Musunuru
2 years
@mbeisen ANGPTL3 was first connected to LDL cholesterol levels by GWAS, ultimately leading to an approved treatment for homozygous familial hypercholesterolemia (evinacumab) and other treatments in development.
0
5
22
@kiranmusunuru
Kiran Musunuru
3 years
10/ The investigators did note the potential for off-target editing at 7 sites in the human genome—observed in 1º human hepatocytes in vitro only at much higher LNP doses than would ever be used in patients—though all are in noncoding DNA (less likely to affect gene function).
Tweet media one
1
7
21
@kiranmusunuru
Kiran Musunuru
4 years
16/ Alex Chadwick in my lab @PennMedicine used base editing in mouse liver to efficiently introduce nonsense mutations into PCSK9 or ANGPTL3. With ⬇️ANGPTL3 in mice with high cholesterol, she observed: >50%⬇️triglycerides >50%⬇️LDL A double whammy!
Tweet media one
1
5
21
@kiranmusunuru
Kiran Musunuru
1 year
Tweet media one
Tweet media two
0
0
22
@kiranmusunuru
Kiran Musunuru
3 years
Today is the 3rd anniversary of the announcement of the world’s first gene-edited babies, a scientifically and ethically dubious milestone. From @metricausa , an important update on the health of the CRISPR children—Lulu, Nana, and Amy—in @NatureBiotech
@metricausa
Vivien Marx🐘📬⛅️
3 years
The CRISPR children. My latest story in @NatureBiotech , three years in the making. Thank you so much to those willing to be interviewed. So very many said: Noooo, go away, not taking about that!! Thank you to my editors. My sources. A first 🧵
4
77
267
2
5
20
@kiranmusunuru
Kiran Musunuru
3 years
5/ In a proof-of-concept study published in 2018, @intelliatweets demonstrated durable editing of TTR in mouse liver using LNP-delivered CRISPR-Cas9, resulting in >97% ⬇️ blood TTR with single 3-mg/kg LNP dose, stable out to 1 year.
Tweet media one
1
4
20
@kiranmusunuru
Kiran Musunuru
4 years
11/ Subsequent work has shown PCSK9 editing persists for months to years in animal models—and might be permanent in human patients. A one-and-done gene-editing therapy would be a new approach to reducing the 18 million deaths/year from ❤ disease.
1
4
22
@kiranmusunuru
Kiran Musunuru
3 years
Soon after the announcement of a transplanted gene-edited porcine heart into a human patient, now a report of transplanted kidneys!
3
6
22
@kiranmusunuru
Kiran Musunuru
11 months
6/n That’s a wrap! One (of many) big implications for the field: the 🚪 is wide open for precise corrective editing to definitively treat grievous genetic diseases centered in the liver, including inborn errors of metabolism. Stay tuned! 🧬
@kiranmusunuru
Kiran Musunuru
1 year
When I started working on #CRISPR to fight heart disease >10 years ago, I never imagined it might lead to cures for rare inborn errors of metabolism. Here’s how it’s happening! Presented/published today #ASHG23 #ASHG2023 @GeneticsSociety plenary + @AJHGNews + @HGGAdvances 🧵
Tweet media one
2
92
361
1
5
21
@kiranmusunuru
Kiran Musunuru
3 years
9/ One patient had 96% ⬇️ blood TTR—essentially complete elimination! (Of note, 2 additional groups of patients receiving higher LNP doses are planned.) No patient had serious adverse events or significant LFT elevations, with 1 patient having a mild infusion-related reaction.
Tweet media one
1
4
19
@kiranmusunuru
Kiran Musunuru
4 years
18/ The challenge now is to translate the gene editing to live human patients. In 2018, @skathire , @JKeithJoung , & I were the scientific co-founders of @VerveTx , for which I serve as senior scientific advisor and where I’ve been on sabbatical this year.
1
2
21
@kiranmusunuru
Kiran Musunuru
5 years
4/ (This is puzzling. Surely JK understood that his talk at the Second International Summit on Human Genome Editing in Hong Kong would be the most important talk of his career to date. How did he mix up such critical information when making his slide?)
Tweet media one
1
3
18
@kiranmusunuru
Kiran Musunuru
4 years
3/ We scoured the literature and found that Dr. Gustav Schonfeld @WUSTLendo —an Auschwitz survivor, an immigrant to the US, a foremost expert on lipid metabolism—had identified 4 *healthy* siblings with a “double whammy”: ⬇️⬇️LDL & ⬇️⬇️triglycerides (TG)
1
4
19
@kiranmusunuru
Kiran Musunuru
4 years
10/ Our immediate thoughts: if CRISPR works so well in cells in a dish, would it work in a living animal? Could it be therapy? When Ding delivered CRISPR-Cas9 targeting PCSK9 into adult mouse liver via an adenoviral vector: >50% editing ≈90%⬇️PCSK9 in blood ≈40%⬇️cholesterol
Tweet media one
2
5
20
@kiranmusunuru
Kiran Musunuru
4 years
7/ While at @MassGeneralNews , I met @JKeithJoung —a foremost expert on gene editing—and learned from him how to make and use zinc-finger nucleases (ZFNs) to edit cells. As I was starting my own lab @HSCRB , I used ZFNs and then TALENs to edit stem cells for ❤️ disease modeling.
Tweet media one
2
4
19
@kiranmusunuru
Kiran Musunuru
5 years
6/ My condemnation was harsh because I understood that JK’s actions were both an ethical fail and a scientific fail. A single figure from JK’s manuscript is enough to see why I was (and remain) so upset. If you can’t instantly see what’s wrong—you should NOT gene-edit embryos!
Tweet media one
3
7
19
@kiranmusunuru
Kiran Musunuru
4 years
2/ Inspired by work from Boileau/Seidah/Breslow/Horton/Hobbs/Cohen/et al.: 1. Activating PCSK9 mutations = ⬆️LDL cholesterol 2. Inactivating mutations = ⬇️LDL & ⬇️heart disease 3. People with no PCSK9 = ⬇️⬇️LDL & *healthy*! We asked: are there more PCSK9’s to be discovered?
Tweet media one
1
5
18
@kiranmusunuru
Kiran Musunuru
11 months
3/n IT WORKS!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
2
18
@kiranmusunuru
Kiran Musunuru
2 years
Edits to a cholesterol gene could stop the biggest killer on earth
3
7
18
@kiranmusunuru
Kiran Musunuru
5 years
In his manuscript, He Jiankui (JK) barely mentions mosaicism—he didn’t realize (or didn’t care?) that the twins’ embryos were flagrantly mosaic. But he does say “No off-targets, large deletions or pathogenic cancer gene mutations was observed.” His data say otherwise. (thread)
Tweet media one
@kiranmusunuru
Kiran Musunuru
5 years
Lulu and Nana, humanity’s first gene-edited babies, both have some CRISPR edits in the CCR5 gene, as He Jiankui (JK) attempted. His goal was to confer HIV resistance. Unfortunately, the editing turned out quite badly, as shown by *his own data* in *his own manuscript*. (thread)
Tweet media one
3
136
186
1
11
19
@kiranmusunuru
Kiran Musunuru
5 years
5/ If you know what to look for, you can immediately tell there’s something wrong with this picture. If there are only 2 alleles—one wild-type, one with a deletion—there should be at most 2 peaks in any 1 position of the chromatogram. Do you see any positions with >2 peaks?
Tweet media one
1
3
17
@kiranmusunuru
Kiran Musunuru
4 years
12/ PCSK9 became a test gene for innovations in therapeutic gene editing. The lab of @zhangf delivered a small Cas9 (SaCas9) via an AAV vector into mouse liver to ⬇️ PCSK9. Daniel Anderson’s lab @MIT used lipid nanoparticles (LNPs) to deliver Cas9 into mouse liver to ⬇️ PCSK9.
Tweet media one
Tweet media two
1
2
18
@kiranmusunuru
Kiran Musunuru
5 years
4/ It’s generally understood that JK’s effort was an ethical disaster. What’s not well known—it was also a scientific disaster. Though JK’s manuscript hasn’t been published, it reveals just how much of a disaster. It’s time for the biomedical community to know the full truth.
Tweet media one
2
11
17
@kiranmusunuru
Kiran Musunuru
4 years
6/ ANGPTL3 was known to be linked to TG in mice, but not LDL. That same year, GWAS of 100,000 people by @skathire , me, & many colleagues ➡️ common variants near ANGPTL3 linked to TG & LDL. Thus: ⬇️PCSK9 = safe ⬇️LDL ⬇ANGPTL3 = safe ⬇️LDL & ⬇️TG = candidate drug targets.
Tweet media one
1
5
18
@kiranmusunuru
Kiran Musunuru
3 years
A quantum leap in gene editing technology!
@jgooten
Jonathan Gootenberg
3 years
New preprint! How do you insert large genes efficiently + programmatically? CRISPR-based methods are programmable, integrases are efficient. Why not combine them? PASTE places short (~45bp) integrase landing sites that serve as beacons for insertion (up to 36kb)! @omarabudayyeh
5
81
405
0
5
16
@kiranmusunuru
Kiran Musunuru
3 years
7/ In non-human primates, there was dose-dependent editing of TTR (up to 73% editing with 6-mg/kg LNP dose, consistent with editing of all hepatocytes) and ⬇️ blood TTR (up to >94% reduction) with single LNP doses, stable out to 1 year.
Tweet media one
1
3
16
@kiranmusunuru
Kiran Musunuru
4 years
13/ Xiao Wang in my lab used @Yecuris liver-humanized mice—the mouse’s own liver replaced with transplanted human liver cells—to show that Cas9 edits human PCSK9 in human liver cells in vivo efficiently. Conclusion: if we could get Cas9 into the human liver, it would ⬇️ PCSK9.
Tweet media one
1
5
17
@kiranmusunuru
Kiran Musunuru
5 years
8/ Over the coming days, I’m going to tweet at length about the scientific and ethical shortcomings of JK’s actions. My hope is to bring to light and explain aspects of JK’s actions that have remained unclear, a year later. Can’t wait? Want the full story in a single read?
Tweet media one
1
3
17
@kiranmusunuru
Kiran Musunuru
5 years
13/ There are vocal detractors who bemoan the “billions” in taxpayer money spent on GWAS. Yes, it was a lot of money. But even if all that comes from it is a cure for sickle cell disease & beta thalassemia—IMHO that’s not so bad a return on investment.
Tweet media one
1
6
17
@kiranmusunuru
Kiran Musunuru
4 years
17/ PCSK9 antibodies were shown to reduce ❤️ disease but have to be injected every few weeks. It was now clear that gene/base editing of PCSK9 or ANGPTL3 was also a viable approach to reduce ❤️ disease—1-shot therapies with possibly lifelong protection.
1
7
17
@kiranmusunuru
Kiran Musunuru
5 years
2/ Here’s the first piece of evidence. This is a Sanger sequencing chromatogram of a PCR amplicon of the CCR5 target site, using DNA from cells extracted from Lulu’s embryo prior to pregnancy. In the manuscript, JK claims there’s a wild-type allele and a 15bp deletion allele.
Tweet media one
1
2
16
@kiranmusunuru
Kiran Musunuru
4 years
22/ Here are the non-human primate data presented by @skathire on behalf of @VerveTx in his keynote talk at #ISSCR2020 .
Tweet media one
Tweet media two
Tweet media three
2
1
16
@kiranmusunuru
Kiran Musunuru
4 years
5/ There’s a lot of uncertainty when it comes to genetic testing. But what *is* certain is the indispensable role of genetic counselors in caring for patients both before and after genetic testing. #GeneticCounselors @GeneticCouns
Tweet media one
2
7
15
@kiranmusunuru
Kiran Musunuru
5 years
15/ We don’t know for sure, because JK’s team never had the chance to evaluate the babies themselves. Maybe that’s for the best.
Tweet media one
1
3
14
@kiranmusunuru
Kiran Musunuru
5 years
12/ That’s it for today. Tomorrow, I’ll start doing a deep dive and analyze some of the key figures from JK’s manuscript. Again, if you don’t want to wait, you can go to and get the eBook version of #TheCRISPRGeneration immediately.
Tweet media one
Tweet media two
5
3
16
@kiranmusunuru
Kiran Musunuru
5 years
12/ JK showed the chromatograms in his Summit talk. Did he not understand his own data, either before or after the pregnancy? A savvy viewer could have picked up on the problems (if JK hadn’t rushed through his slides). @GaetanBurgio was one of the first to note the mosaicism.
Tweet media one
1
2
13
@kiranmusunuru
Kiran Musunuru
4 years
A remarkable advance in gene editing from @liugroup and collaborators!
@davidrliu
David R. Liu
4 years
Today we report in @nature , in collaboration with the labs of Joseph Mougous and @VamsiMootha , the development of a new class of CRISPR-free base editors that enable precision editing of mitochondrial DNA (mtDNA) for the first time. 1/7
28
475
2K
1
2
16